HomeAI · summaries
Storia in 2 fonti
DNA treatment cuts bad cholesterol by nearly 50% without statins
Researchers have designed a new DNA-based treatment that targets PCSK9, a protein closely tied to high LDL cholesterol and atherosclerosis. Their most effective molecule reduced PCSK9 protein by 87% in human liver cells and lowered cholesterol by 47% in genetically modified mice after a single injection.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
sciencedaily.com
DNA treatment cuts bad cholesterol by nearly 50% without statins
Researchers have designed a new DNA-based treatment that targets PCSK9, a protein closely tied to high LDL cholesterol and atherosclerosis. Their most effective molecule reduced…
- ·
nature.com
CRISPR therapy cuts cholesterol for at least 12 months
Small trial targeted liver proteins that play a part in the regulation of lipid levels.